Tag: BHARAT BIOTECH COVAXIN

Bharat Biotech firmly condemns baseless reports on COVAXIN Development

Bharat Biotech today strongly condemned fallacious and misleading information report recently by a foreign media. The company in

India’s COVAXIN, Long Awaited in the US to be Evaluated by FDA

COVAXIN maker Bharat Biotech announced today that U.S. Food and Drug Administration (FDA) has lifted its clinical hold

COVAXIN booster boosts antibody levels by 19-97 fold against variants – Latest Results

COVAXIN booster increases 19-97 fold rise in antibody levels against Covid-19 variants of concern. Results from the highly

COVAXIN Open Vial: Do Not Worry About its Wastage

Bharat Biotech, India's indigenous vaccine maker noted that health care workers do not have to worry about COVAXIN

Vietnam to Receive 2 Lakh COVAXIN from Bharat Biotech as Donation

The Republic of Vietnam will receive 2,00,000 doses of Bharat Biotech COVAXIN®. Dr. Krishna Ella, Chairman and Managing

COVAXIN Protects You From Multi- Covid-19 Variants – New NII study

COVAXIN, India's Indigenous vaccine developed by Bharat Biotech unlike existing vaccines against , it has been found that

COVAXIN is a Triumph Over COVID-19 Pandemic

Developing India's first indigenous Vaccine COVAXIN under 10 months was a tremendous challenge. Bharat Biotech Director, V Krishna

CDSCO Extends India’s COVAXIN Shelf Life to 12 Months Now

The Central Drugs Standard Control Organisation (CDSCO) has approved the extension of Covid-19 vaccine Covaxin Shelf Life to

Australia Now Welcomes COVAXIN-ated – It’s Official

Covaxin - ated can cheer today, as Australia today officially announced it will open its doors to inbound

Book Going Viral Now: The Inside Story of COVAXIN

COVAXIN The Success of India's Indigenous COVID-19 Vaccine developed by Bharat Biotech in partnership with ICMR and NIV

India Recommends Bharat Biotech’s COVAXIN for Kids Under 12 Years

Bharat Biotech's COVID-19 vaccine for children under 12 years of age has got India's Subject Expert Committee nod.

News in Brief: ICMR New Study to cheer COVAXIN- ated

An ICMR New Study will cheer those who were administered COVAXIN. According to the study announced COVAXIN single